Literature DB >> 8533672

[Seminal plasma cytokines in nonbacterial prostatitis: changes following sparfloxacin treatment].

R Yasumoto1, M Kawano, T Tsujino, Y Iwai, S Hayashi, N Nishisaka, A Horii, T Kishimoto.   

Abstract

The detection of various cytokines; interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), was studied in patients with nonbacterial prostatitis (NBP), and the clinical efficacy of sparfloxacin was also reported. The seminal plasma of 11 normal men and 10 patients with NBP were examined for the cytokines. There was no IL-1 beta or IL-6 in the seminal plasma of normal men. TNF-alpha was detected in only one normal man. In the seminal plasma of the patients, IL-1 beta was detected in 2 out of 10, and IL-6 was also detected in 6. TNF-alpha was detected in 6 out of 10 patients with NBP. The rate of detection of IL-6 and TNF-alpha was significantly higher in the patients with NBP than in normal men. The average levels (range) of IL-1 beta, IL-6 and TNF-alpha were 28 pg/ml (27-29), 110 pg/ml (25-476) and 25 pg/ml (6-113), respectively. After treatment with sparfloxacin at a dose of 100 mg to 200 mg per day, their symptoms disappeared. The number of leukocytes in the seminal plasma decreased to the normal level and these cytokines were not detected. The favorable clinical effect was achieved in 13 of the 17 patients (76%). These findings suggested that the cytokines have an important role in the pathogenesis of prostatitis and that the level of the cytokines are useful indicators in patients with prostatitis, particularly with NBP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8533672

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  5 in total

1.  The 6-fluoro-8-methoxy quinolone gatifloxacin down-regulates interleukin-8 production in prostate cell line PC-3.

Authors:  Koh Takeyama; Hiroaki Mitsuzawa; Chiaki Nishitani; Takeyuki Shimizu; Hitomi Sano; Yasuharu Kunishima; Satoshi Takahashi; Hiroshi Hotta; Masanori Matsukawa; Ken-Ichiro Shibata; Taiji Tsukamoto; Yoshio Kuroki
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

2.  Quinolone-induced upregulation of osteopontin gene promoter activity in human lung epithelial cell line A549.

Authors:  Beata Shiratori; Jing Zhang; Osamu Usami; Haorile Chagan-Yasutan; Yasuhiko Suzuki; Chie Nakajima; Toshimitsu Uede; Toshio Hattori
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

3.  In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.

Authors:  H Thadepalli; U Reddy; S K Chuah; F Thadepalli; C Malilay; R J Polzer; N Hanna; A Esfandiari; P Brown; S Gollapudi
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

Review 4.  [Seminal cytokines: is quantification useful in urogenital disorders?].

Authors:  A Pilatz; C Hudemann; F Wagenlehner; H-C Schuppe; T Diemer; W Weidner; H Renz; T Bschleipfer
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

5.  Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines.

Authors:  Taly Weiss; Itamar Shalit; Hannah Blau; Sara Werber; Drora Halperin; Avital Levitov; Ina Fabian
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.